MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$1,628,269K
Cash and cash
equivalents
$347,559K
Prepaid expenses and
other current assets
$9,843K
Total property and
equipment, gross
$206,903K
Total current assets
$1,985,671K
Operating lease assets
$131,724K
Property and equipment,
net
$115,851K
Other non-current
assets
$24,368K
Restricted cash
$7,629K
Accumulated depreciation
$91,052K
Total assets
$2,265,243K
Total liabilities and
shareholders equity
$2,265,243K
Total shareholders
equity
$1,921,813K
Total liabilities
$343,430K
Accumulated deficit
-$1,947,551K
Treasury shares, at cost,
115,316 and 170,316...
$60K
Additional paid-in capital
$3,861,516K
Operating lease
liabilities, net of current...
$188,168K
Total current
liabilities
$149,120K
Other non-current
liabilities
$6,142K
Accumulated other
comprehensive income
$4,821K
Common shares, chf 0.03
nominal value,...
$3,087K
Accrued expenses
$89,407K
Operating lease
liabilities
$18,578K
Deferred revenue,
current
$15,771K
Other current
liabilities
$13,113K
Accounts payable
$11,138K
Accrued tax liabilities
$1,113K
Back
Back
Balance Sheet
source: myfinsight.com
CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG (CRSP)